FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like MorphoSys AG To Present At Upcoming Investor Conferences August 9, 2017 DBV Technologies Surges as Peanut Allergy Drug Passes Phase III Test November 19, 2017 Drug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal February 15, 2018
